Design and Baseline Data of a Randomized Trial to Evaluate Coverage and Frequency of Mass Treatment with Azithromycin: The Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia

REFERENCES

• Mariotti, SP, Pascolini, D, Rose-Nussbaumer, J. Trachoma: Global magnitude of a preventable cause of blindness. Br J Ophthalmol 2009; 93(5):563–568.
   Google Scholar
• Jansen, E, Baltussen, RM, van Doorslaer E, Ngirwamungu E, Nguyen MP, Kilima PM. An eye for inequality: how trachoma relates to poverty in Tanzania and Vietnam. Ophthalmic Epidemiol 2007; 14(5):278–287.
   Google Scholar
• Frick, KD, Basilion, EV, Hanson, CL, Colchero, MA. Estimating the burden and economic impact of trachomatous visual loss. Ophthalmic Epidemiol 2003; 10(2):121–132.
   Google Scholar
• Baltussen, RM, Sylla, M, Frick, KD, Mariotti, SP. Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol 2005; 12(2):91–101
   Google Scholar
• Solomon, AW, Zondervan, M, Kuper, H, Buchan, JC, Mabey, DCW, Foster, A. Trachoma control: a guide for programme managers. Geneva, Switzerland: World Health Organization; 2006.
   Google Scholar
• Report of the Eighth Meeting of the WHO Alliance for the Global Elimination of blinding Trachoma. Report of a WHO Working Group. 2004; World Health Organization Geneva, Switzerland. WHO/PBD/GET/04.2
   Google Scholar
• Burton, MJ, Holland, MJ, Makalo, P, Aryee, EA, Alexander, ND, Sillah, A, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005; 365(9467):1321–1328.
   PubMedGoogle Scholar
• Solomon, AW, Holland, MJ, Alexander, ND, Massae, PA, Aguirre, A, Natividad-Sancho, A, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004; 351(19):1962–1971.
   Google Scholar
• Melese, M, Chidambaram, JD, Alemayehu, W, Lee, DC, Yi, EH, Cevallos, V, et al. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. JAMA 2004; 292(6):721–725.
   PubMedGoogle Scholar
• Chidambaram, JD, Alemayehu, W, Melese, M, Lakew, T, Yi, E, House, J, et al. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 2006; 295(10):1142–1146.
   Google Scholar
• West, SK, Munoz, B, Mkocha, H, Holland, MJ, Aguirre, A, Solomon, AW, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005; 366(9493):1296–1300.
   PubMedGoogle Scholar
• Solomon, AW, Harding-Esch, E, Alexander, ND, Aguirre, A, Holland, MJ, Bailey, RL, et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Engl J Med 2008; 358(17):1870–1871.
   Google Scholar
• Bailey, RL. rRNA-based tests for chlamydial infection in trachoma. Br J Ophthalmol 2007; 91(3):271.
   Google Scholar
• Mkocha, H, Munoz, B, West, S. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme. Tanzania Journal of Health Research 2009; 11(3):103–10.
   Google Scholar
• Faal, H, Minassian, DC, Dolin, PJ, Mohamed, AA, Ajewole, J, Johnson, GJ. Evaluation of a national eye care programme: re-survey after 10 years. Br J Ophthalmol 2000 Sept; 84(9):948–951.
   Google Scholar
• Dolin, PJ, Faal, H, Johnson, GJ, Ajewole, J, Mohamed, AA, Lee, PS. Trachoma in the Gambia. Br J Ophthalmol 1998 Aug; 82(8):930–933.
   Google Scholar
• Harding-Esch, E, Edwards, T, Sillah, A, Sarr, I, Roberts, CH, Snell, P, et al. Active trachoma and ocular Chlamydia trachomatis infection and in two Gambian regions: on course for 2020? PLoS Negl Trop Dis 2009 Dec 22; 3(12):e573.
   Google Scholar
• Chow, SC, Shao, J, Wang, H. Sample size calculations in clinical research. Boca Raton: Taylor and Francis; 2003.
   Google Scholar
• Chaudhary, MA, Moulton, LH. A SAS macro for constrained randomization of group-randomized designs. Comput Methods Programs BioMed 2006; 83(3):205–210.
   Google Scholar
• Thylefors, B, Dawson, CR, Jones, BR, West, SK, Taylor, HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987; 65(4):477–483.
   Google Scholar
• Solomon, AW, Holland, MJ, Burton, MJ, West, SK, Alexander, ND, Aguirre, A, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003; 362(9379):181–182.
   Google Scholar
• Dalesio, NV, Marsiglia, A, Quinn, TC, Quinn, CA, Gaydos, CA. Performance of the MagnaNA Pure LC for the extraction of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and swab specimens. J. Clin Microbiol 2004; (42):3300–3302.
   Google Scholar
• Diamant, J, Benis, R, Schachter, J, Moncada, J, Pang, F, Jha, HC, et al. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Opthalmic Epidemiol 2001; 8(2–3):109–117.
   Google Scholar
• Mathew, AA, Turner, A, Taylor, HR. Strategies to control trachoma. Drugs 2009; 69(8):953–970.
   Google Scholar